Google Search

Search

Already a Member ?

Best Business Opportunities in Jordan, Middle East - Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship

Reasons for Starting a Business in Jordan?

People opt to start enterprises in Jordan for a variety of reasons. One of these factors is that entrepreneurs believe a domestic market is safer than a foreign market. Another reason is that Jordan, with its free economy and free trade zones, provides many opportunities for success. Furthermore, Jordanian partners are preferred over foreign ones by entrepreneurs. This enhances the likelihood of their business endeavours prospering. Furthermore, because most businesspeople work inside their own social circles or regional groups, they tend to promote one other's firms via word-of-mouth marketing.

 

What are the Natural Resources in Jordan?

Jordan's natural resources include arable land, modest gold and phosphate deposits, limited crude oil supplies, fresh water from springs, and a few tiny hydroelectric units. Despite these natural riches, King Abdullah II has made it a priority for Amman to become more attractive for foreign investment in order to strengthen the Jordanian economy. He has tried to reduce government bureaucracy, develop free trade zones with favourable tax rates, and provide incentives for businesses operating in Jordan's free zones by exempting them from taxes for up to 15 years as part of his proposal.

 

What are The business Opportunities in Jordan?

Jordan, a service or manufacturing business is definitely your best chance.

Make important to examine what is currently successful in your country when picking which business to start. If you're opening a restaurant, for example, try a variety of dishes to determine which ones are the most popular with guests. From there, you can construct your own recipes utilising regionally typical items. This will assist you in becoming more acquainted with Jordanian culture and provide you with an understanding of what Jordanians expect from their food. It also offers you an idea of how competitive the business environment in your area to open one on your own When determining which business to start, examine what is currently succeeding in your industry. While many investors are interested in Jordan's real estate market, there are other investment opportunities accessible. Agriculture offers numerous opportunities. If you want to invest in agricultural or food processing, he says there's a lot of promise here. It's a fantastic time, in my opinion, because we need investments now more than ever.is. If there appear to be numerous other restaurants in the area selling identical meals, it may not be worth your time and money.

Business-Friendly Policies and Government Initiatives;

Jordan was placed 27th in the World Bank's annual report Doing Business 2014, which evaluates business regulations around the world. The government took significant steps to improve efficiency and openness, including the implementation of an e-governance system that allows businesses to apply for permits and licences electronically. Small-business awards from various government agencies also help entrepreneurs; numerous multinational companies have built up assistance centres for small businesses near their headquarters in Amman. Furthermore, there is significant public-private sector collaboration to improve financial access and skills training.

Private consumption (68%) is the most important driver of the Jordanian economy, followed by services (24%), and industry (24%). (8 percent). While it is critical, It's critical for any entrepreneur to be aware of economic conditions in his or her place of operation, but it's especially important for those trying to expand into countries outside of Western Europe or North America, as consumer purchasing patterns differ greatly.

 

Jordan Industrial Infrastructure

There's nothing like knowing that your products and services will have access to critical infrastructure when it comes to starting a business. Companies of all sizes must be able to engage with and serve customers on a global scale in today's hyper-connected world, where enterprises are no longer bound by boundaries. Nations all over the world know that building robust infrastructure networks offers inhabitants with new chances for prosperity and attracts outside investment. Jordan is positioning itself as a key site for foreign investment and entrepreneurship by actively crafting its own industrial destiny. Better transit alternatives, fewer logistical costs, greater economic stability, and a higher quality of life are all benefits of solid infrastructure, and these aspects make Jordanian entrepreneurs more competitive on the global stage.

 

What are the steps for Starting a Business in Jordan?

(1) company registration; (2) trademark registration; (3) trademark registration; (4) trademark registration; (5) trademark registration; (6) trademark registration;

 

(3) Look for an office or place to rent or own. To make things easier, we've compiled a list of all of them here: It is relatively simple to register your business in Jordan. You can register your company online through the JORDAAN website. After that, you should apply for a trade name at the Intellectual Property Center (IPC).

 

(4) The next stage is to look for a suitable office or workspace. In Amman, there are numerous real estate brokers who can assist with business space and rents. The next step is to select staff and, if applicable, partners, as well as open a bank account and complete other requirements associated with starting a new business in Jordan.

 

(5) Finally, you must publicise your services.

That concludes our discussion. Good luck on your path to being a successful Jordanian business.

 

Market size of Jordan

Jordan's overall GDP was estimated by The World Bank to be $37.664 billion in 2012, giving it an average per capita income of $5,700. Jordan's economy has steadily developed throughout time, with per capita income and living standards increasing steadily until 2000. Jordan is one of the most attractive countries for foreign investors, according to a JETRO report (2016), due to its increasing market, diverse economic sectors, and government programmes targeted at stimulating investment. In 2015, gross capital creation totaled JD 3.2 billion, with domestic investments accounting for 70% and foreign investments accounting for 30%. With a population of 9.5 million people and rising, there is plenty of room for new enterprises. Jordan also boasts a 2.5 percent yearly growth rate, which is above the global average. will become more prevalent over time $48.8 billion in 2015 – $67.1 billion in 2016, accounting for 3.2 percent of the overall regional market and expected to expand at a rate of 5% per year through 2020; Business population: 2 million persons out of a total population of 10 million, with 60% living in Greater Amman and 25% in the Aqaba Free Zone (Jan 2018). Due to rapid expansion and increasingly permissive rules that have helped enhance foreign investment and cross-border commerce, the Jordanian market presents a fantastic potential for new businesses.

 

Industrial Growth

More over 40% of Jordanian businesses were held by foreigners. Jordan's status as an economic powerhouse in the area has been boosted by the expansion of manufacturing, tourism, and other significant industries. These businesses also make a substantial contribution to Jordan's GDP. Indeed, according to Arab Advisors Group, the industrial and services sectors play a significant role in employment rates, which are now at 53% for men and 32% for women, as well as foreign exchange rates and capital income within the country. Jordan's Industrial Growth Program is a project led by and for the country's industrial sector. Its goal is to support SMEs in modernising and becoming competitive on regional and worldwide markets by providing training, export assistance, and networking opportunities.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 14 of 27 | Total 263 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 26 27   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Best Business Opportunity to Start Dairy Farming & Dairy Products, Groundnut Oil, Nicotine from Tobacco Waste, IV Fluids (BFS Technology), Disposable Nitrile Gloves, Toothpaste, Active Pharma Ingredients (API),

Best Business Opportunity to Start Dairy Farming & Dairy Products, Groundnut Oil, Nicotine from Tobacco Waste, IV Fluids (BFS Technology), Disposable Nitrile Gloves, Toothpaste, Active Pharma Ingredients (API), Are you searching for manufacturing business ideas? If you have sizeable money to invest and a more risk-taking ability, starting a business is a good decision. Product manufacturers can generate new value, minimize costs, and increase operational stability by focusing and prioritizing on four broad areas: production, product design, value recovery, and supply-chain management. Thinking about stepping into manufacturing industry business, you need to consider the option of starting on a limited size production. Starting with the making of essential components of the various industries. Once you set up things well, you could choose to start an industry and gradually become the giant of the industry. Projects:- Project Reports & Profiles Get ready and quickly go through these top business ideas that are the best options available with high return on investment. Choose any of these high net profit margin ideas if you want to start a venture in the manufacturing industry. Becoming an entrepreneur easier than ever before—technology is shrinking the world, opening markets, and making it possible for many people to strike out on their own in the field of their dreams. An entrepreneur who starts his own business can break free from this actuarial perspective and redefine the value he brings to the market. Books:- BOOKS & DATABASES Dairy Farming & Dairy Products (Milk, Butter, Ghee & Paneer) Dairy farming may be a class of agriculture for long-term production of milk, which is processed for eventual sale of a dairy product. Dairying is a very important source of subsidiary income to small/marginal farmers and agricultural laborers. India derives nearly 33% of the gross Domestic population from agriculture and has 66% of economically active population, engaged in agriculture. The share of livestock product is estimated at 21% of total agriculture sector. Milk production alone involves over 70 million producers, each raising one or two cows/buffaloes primarily for milk production. Additionally to exploit, the manure from animals provides an honest source of organic matter for improving soil fertility and crop yields. The gobar gas from the dung is used as fuel for domestic purposes as also for running engines for drawing water from well. In Hinduism; cow urine features a special significance as a drink. Sprinkling of cow urine is said to possess a spiritual cleansing effect furthermore. Gomutra isn't a toxic industrial waste material. 95% of its water, 2.5% consists of urea, and therefore the remaining 2.5% may be a mixture of minerals, salts, hormones and enzymes. Related Projects:- Milk & Dairy Products The global dairy products market is expected to grow at a CAGR of 5.2% from 2019 to reach $645.8 billion by 2025. Dairy is defined as a business enterprise that deals with the processing and harvesting of animal milk for human consumption. Some of the common milch animals include cow, goat, buffalo, camel and sheep. The milk obtained from these animals can be consumed directly and processed into ice cream, cheese, paneer, butter, ghee, condensed milk and yogurt. These products offer various nutrients such as calcium, proteins, zinc, magnesium, and vitamin D and B12. With widespread demand for dairy products and their proactive function in the global food industry, dairy plays a crucial role in the growth of the economies worldwide. Over the years, the dairy industry has witnessed improvements in product safety through specialization, modernization and consolidation. Moreover, advancements in global trade have also influenced the profitability of dairy farms. Related Books:- Milk Processing, Dairy & Dairy Products, Poultry Industries As of 2018, India is the leading milk producing country in the world, accounting for ~19% of the global market share. The milk processing industry in India is expected to expand at a compound annual growth rate (CAGR) of ~14.8% between FY 2018 and FY 2023, and will reach INR 2,458.7 Bn in FY 2023. Groundnut Oil Groundnut oil may be a vegetable oil derived from groundnuts. It’s also called groundnut oil. The oil features a strong peanut flavor and aroma. It’s often utilized in American, Chinese, South Asian and Southeast Asian cuisine, both for general cooking, and within the case of roasted oil, for added flavor. Unrefined groundnut oil features a smoke point of 320°F/160°C and is employed as a flavor ant for dishes like sesame oil. Groundnut haulms are nutritious and widely used for feeding livestock. The groundnut oil consists of mixed glycerides, and contain a high proportion of unsaturated fatty acids, especially Oleic (50-56%) and Linoleic (18-30%). Related Projects: - Edible Oils Projects In India, groundnut is cultivated in 5.8 million hectares. Gujarat is that the highest producer of groundnut oil in India. Groundnut seed contains 50-55% of the oil. It’s one among the most effective oil seeds to extract oil from. Increasing use of groundnut oil in cosmetics are getting to be one altogether the primary drivers of the peanut oil market. The abrasive, volatizing, and cleansing properties of hot-pressed groundnut oil and its derivatives are boosting its application in BPC product and cosmetics, such as moisturizers and skin cleansers. Growing popularity of blended oil are getting to be one altogether the critical groundnut oil market trends. The utilization of cheap alternatives, similar to oil in blended oil makes it more affordable than conventional oil. These advantages can boost the popularity of homogenized groundnut oil and consequently fuel the growth of the groundnut oil market. Related Books:- Market Research Report on Edible Oils in India However, the high production cost of peanut oil is a major factor expected to restraint growth of the target market in the near future. In addition, high consumption of peanut oil results in various side effects in human health which is one of the major factors expected to hamper growth of the target market to a certain extent. Global peanut oil market is set to witness a steady CAGR of 4.25% in the forecast period of 2019- 2026. Nicotine from Tobacco Waste Nicotine may be a natural product of tobacco, occurring within the leaves of nicotiana tabacum during a range of 0.5 to 7.5% counting on variety. Nicotine is additionally found within the leaves of nicotiana rustica, in amounts of 2–14%; in Duboisia hopwoodii and in Asclepias syriaca. Nicotine may be a widely used stimulant and potent par sympathomimetic alkaloid that's naturally produced within the nightshade family of plants. It’s used for smoking cessation to alleviate withdrawal symptoms. Nicotine may be a widely used stimulant and potent para sympathomimetic alkaloid that's naturally produced within the nightshade family of plants. It’s used for smoking cessation to relieve withdrawal symptoms. Related Projects:- Tobacco, Pan Masala, Khaini, Gutkha, Supari, Zarda, Mouth Freshener The India Tobacco Board has authorized a 2020 Traditional FCV crop size of 90 million kilos. However, crop size is estimated at 96 million kilos. A grade spread consisting of 20 million kilos of bright, 25 million kilos of the medium, and 51 million kilos of low style tobacco. 90% of the crop is already harvested. The average market price is USD 2.10 for this year. Indian Tobacco Board has authorized an NLS 2020 crop size of 46 million kilos. However, a crop size 42 million kgs is anticipated which was transplanted in 17,000 hectares and 90% of the crop has been harvested. The average market price is expected to be USD 2.30 for this year. Related Books:- Agriculture, Agro Based, Bakery, Wood, Ice Cream, Corn, Tobacco And Tobacco Products IV Fluids (BFS Technology) Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to guard patients from injury, and there are variety of various types available to be used. Many companies manufacture packaged intravenous fluids, also as products which may be mixed with sterile water to prepare a solution for intravenous administration. Fluids are given when someone's body fluid volume falls. There are variety of things which may cause a drop by fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids once they are sick, to stay their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels within the blood also can become unstable as a result of rapid changes in fluid volume, during which case intravenous fluids are often used to restore the balance. Related Projects:- IV Fluids, I.V. solutions, Intravenous fluids The primary costumers for these manufacturing units are Hospitals, Clinics, Dialysis centers, Home care settings. The global Intravenous Fluid market size was valued at US$ 8,372.0 million in 2019 and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027). The basic function of I.V. fluids is to replenish body fluids. It can also be used in the treatment of electrolyte metabolism, especially in severe cases, therapy of acid-base in balances, the volume substitution and volume replacement in surgery of accident victims suffering blood loss. It can be used as parenteral nutrition for severally ill and post-operative patients. Related Books:- BOOKS & DATABASES Disposable Nitrile Gloves Nitrile gloves are a kind of disposable gloves made up of synthetic rubber, this suggests there's no risk of latex allergies. They the foremost popular gloves type in our range and offer superior strength, dexterity and resistance to oils and aqueous chemicals as compared to vinyl or latex. For these reasons, they're often utilized in the medical, laboratory and manufacturing industries. Nitrile gloves are an excellent compromise between latex and vinyl. Our Blue Nitrile gloves offer protection from bodily fluids providing a barrier that forestalls infection, cross-infection or cross-contamination. Tests revealed that Nitrile gloves are three times more puncture-resistant than rubber gloves. Related Projects:- Disposable Products and Projects from Paper The Indian market for medical gloves is still evolving. While the global market is growing at a compound annual growth rate (CAGR) of two per cent, the Indian market is at seven per cent growth. Every day there is a new hospital or nursing home popping up in India, so the demand for medical gloves is expected to increase. Medical tourism is also driving the growth of this product category in our country. The market size therefore only for gloves in India is Rs 300 crore. In view of all this, there is a good scope to initiate small-scale rubber gloves manufacturing unit. The Global Rubber Gloves market is expected to grow at a CAGR of 8.5% between 2014 and 2022. The factors such as rising healthcare expenditure, increasing health threats and increasing hygiene awareness and healthcare regulations are driving the market growth. Related Video:- Production of Disposable Nitrile Gloves Nitrile gloves are preferred over latex gloves because they resist chemicals, including certain disinfectants such as chlorine. There is a high rate of allergies to latex and contact allergic dermatitis among health workers. Non powdered gloves are preferred to powdered gloves. Toothpaste Toothpaste may be a paste or gel to be used with a toothbrush to maintain and improve oral health and aesthetics. Since their introduction several thousand years ago, toothpaste formulations have evolved considerably - from suspensions of crushed egg shells or ashes to complex formulations with often over 20 ingredients. Among these are often compounds to combat dental caries, gum disease, malodor, calculus, erosion and dentin hypersensitivity. Furthermore, toothpastes contain abrasives to wash and whiten teeth, flavors for the aim of breathe freshening and dyes for better visual appeal. Effective toothpastes are people who are formulated for maximum bioavailability of their actives. This, however, are often challenging as compromises will need to be made when several different actives are formulated in one phase. Related Projects:- Hygiene Products, Essential Personal Hygiene Products The global toothpaste market is projected to grow at a CAGR of 6.1% during the forecast period. The toothpaste market was valued at USD 26.09 billion in 2018, and it is projected to reach USD 36.98 billion by 2024. Increasing dental problems among children and adults, due to poor eating habits, and the rise in popularity for herbal oral care products are the factors primarily driving the global toothpaste market. Related Video:- Startup Business Opportunities in Toothpaste The rapidly changing lifestyle, improper diet, including sugar-rich diets, and therefore the increased consumption of alcohol and tobacco have made oral health one among the main public health problems in almost every a part of the planet. The impact of oral diseases on people's everyday lives is subtle and pervasive, influencing food habits, sleep, rest, social roles, and almost every phase of the day. Collectively, oral diseases and disorders create substantial pain and suffering. Because of this, consumers across the planet have started paying immense attention to maintaining their oral health, which has led to a rise within the sales of toothpaste across the world. Active Pharma Ingredients (API) (Cephalexin, Ampicillin Trihydrate, Ibuprofen and Paracetamol) The Active Pharmaceutical Ingredient (API) is that the part of any drug that produces the intended effects. Some drugs, like combination therapies, have multiple active ingredients to treat different symptoms or act in several ways. Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to chop costs. This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place. Related Projects:- Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing India is that the seventh largest country within the world and has the second highest population. It a parliamentary democratic variety of government and has abundant natural resources and sufficient oil reserves. The country features a huge skilled, English-speaking, and inexpensive labor force. Its young population and current economic policies have made it one among the most important recipients of FDI within the world. Asia Pacific is predicted to be the fastest-growing market over the forecast period. Because of the supply of affordable labor, major companies within the market are setting up API manufacturing plants in developing countries like China and India. The global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 258.8 Billion by 2025, exhibiting a CAGR of 5.6% during 2020-2025. The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. Related Book:- India Active Pharmaceutical Ingredient (API) Market The government also notified a scheme to promote bulk drug parks. For selected parks, financial assistance to the tune of 70 per cent of the project cost of common infrastructure facilities will be provided. In the case of Northeast states and hilly states (Himachal Pradesh, Uttarakhand, Union Territory of Jammu & Kashmir, and Union Territory of Ladakh), financial assistance will be 90 per cent of the project cost. The maximum assistance under the scheme for one bulk Drug Park will be limited to Rs 1,000 crore. The total financial outlay of the scheme is Rs 3,000 crore. Tags:- #dairy #dairyfarming #DairyProducts #dairyindustry #GroundnutOil #Nicotine #tobaccowaste #IVFLUIDS #disposablenitrilegloves #disposablegloves #toothpaste #toothpastebusiness #hygieneindustry #ToothpasteIndustry #ToothpasteMarket #ToothpasteProject #activepharmaingredients #API #apimanufacturing #Apiproduction #ActivePharmaceuticalIngredient #pharmaceuticalindustry #apimarket #businessconsultant #businessfeasibilityreport #DetailedProjectReport #EntrepreneurIndia #startupideas #NPCS
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes

Disposable Syringes are made of plastic material and are used in the field of medical and veterinary science. Due to their availability in sterilized condition, ready to use, and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. The constantly increasing use of this type Syringe indicates its importance which is based mainly on the advantages it offers regarding cost and hygienic applications. The manufacture of plastic syringes has been developed to such a degree that the products now satisfy the requirements and standards set by Hospital and physicians. At the same time they offer the best possible technique of application to the physician and the highest possible degree of safety to the patient. In medical industries syringes are very important and play a significant role. It is a medical device which is used to inject or withdraw fluids from the body. Numerous categories of syringes are used by medical experts depending on the situations. The aim behind using syringes is to clean wounds by infusing fluids into body. Syringes are used for distillation of blood, for vaccination, for infusing of insulin, for governing anesthesia etc. The market of medical disposables holds the revenue of approximately USD 225 billion in 2016 at a CAGR of around 7% over the forecast period i.e. 2016-2024 in which global syringes market accounted for USD 5 billion in 2016 due to increasing number of chronic diseases and so on. On the basis of products disposable syringes are the dominating market with a CAGR of around 6% over the forecast period i.e. 2016-2024 because disposable syringes are used only once ensuring the safety of patients. On the basis of material, glass syringe is dominating the segment and is expected to reach a value of USD 15 million by 2024 because they can be sterilized and reused. The syringes market is expected to reach USD 15.99 Billion by 2021 from USD 10.56 Billion in 2016, at a CAGR of 8.7% during the forecast period. Thus, due to demand it is best to invest in this project.
Plant capacity: Disposable Plastic Syringes 1 ml Size: 720 Boxes / Day (Each Boxes = 100 Pcs) Disposable Plastic Syringes 5 ml Size : 720 Boxes / Day (Each Boxes = 100 Pcs) Disposable Plastic Syringes 10 ml Size : 720 Boxes / Day (Each Boxes = 100 Pcs) Disposable PlPlant & machinery: Rs 513 lakhs
Working capital: -T.C.I: Cost of Project: Rs 1300 lakhs
Return: 28.00%Break even: 63.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac sodium • Acecloflenac

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components used in the drug is known as "formulation." The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising population in this region. According to WHO, around 65% of all cancer deaths occur in developing countries and the number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to 11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy diet, insufficient physical activity and the harmful use of alcohol in this region. The active pharmaceutical ingredients market gets a major boost from the growing prevalence of cardiovascular conditions, infectious diseases, and various other chronic disorders. Other than these, the rise in various genetic disorders has driven the use of biologicals and biosimilars, the world over. In many instances, biosimilars are the most preferred owing to them being low-cost. Biosimilars have the potential of creating a highly sustainable healthcare system which makes way for innovation, allowing more patients to receive the optimum care. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Sanofi India Ltd. Piramal Enterprises Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd.
Plant capacity: Azithromycin: 500 Kgs / Day Cefixime: 500 Kgs / Day Telmisartan: 50 Kgs / Day Diclofenac Sodium: 500 Kgs / Day Aceclofenac: 500 Kgs / DayPlant & machinery: Rs 155 lakhs
Working capital: -T.C.I: Cost of Project : Rs 729 lakhs
Return: 31.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac sodium • Acecloflenac

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components used in the drug is known as "formulation." The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising population in this region. According to WHO, around 65% of all cancer deaths occur in developing countries and the number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to 11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy diet, insufficient physical activity and the harmful use of alcohol in this region. The active pharmaceutical ingredients market gets a major boost from the growing prevalence of cardiovascular conditions, infectious diseases, and various other chronic disorders. Other than these, the rise in various genetic disorders has driven the use of biologicals and biosimilars, the world over. In many instances, biosimilars are the most preferred owing to them being low-cost. Biosimilars have the potential of creating a highly sustainable healthcare system which makes way for innovation, allowing more patients to receive the optimum care. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Sanofi India Ltd. Piramal Enterprises Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd.
Plant capacity: Azithromycin: 500 Kgs / Day Cefixime: 500 Kgs / Day Telmisartan: 50 Kgs / Day Diclofenac Sodium: 500 Kgs / Day Aceclofenac: 500 Kgs / DayPlant & machinery: Rs 155 lakhs
Working capital: -T.C.I: Cost of Project : Rs 729 lakhs
Return: 31.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

Lithium Ion Battery (Battery Assembly)

Lithium batteries are now powering a wide range of electrical and electronically devices, including laptop computers, mobile phones, power tools, telecommunication systems and new generations of electric cars and vehicles. Lithium metal batteries and lithium ion batteries. Basically, the difference between them is that lithium metal batteries are those that are not rechargeable, thus, primary, and lithium ion batteries are those that can be recharged. As an example, your laptop or cell phone is likely to have a lithium ion battery, whereas your watch may have a lithium metal battery. The India lithium-ion battery market is expected to grow at a robust CAGR of 29.26% during the forecast period, 2018-2023. The Indian automobile sector is one of the most prominent sectors of the country, accounting for nearly 7.1% of the national GDP. The industry produced a total of 25.31 million vehicles, including commercial, passenger, two, and three vehicles and commercial quadricycle in April-March 2017, as against 24.01 million in April-March 2016. However, India has set itself an ambitious target of having only electric vehicles (EV) by 2030, which is expected to increase the demand for lithium-ion batteries in India, significantly. “In the coming years, India is expected to witness substantial investments by various companies to set up their Li-ion battery manufacturing base in the country. Entrepreneurs who invest in this project will be successful. Few Indian major players are as under H B L Power Systems Ltd. Luminous Power Technologies Pvt. Ltd. Okaya Power Pvt. Ltd. Eon Electric Ltd. Carborundum Universal Ltd. Bharat Electronics Ltd.
Plant capacity: 48 Volt, 60 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 80 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 100 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 20 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 30 AH Lithium-Ion Battery PacPlant & machinery: Rs 306 lakhs
Working capital: -T.C.I: Cost of Project : Rs 648 lakhs
Return: 28.00%Break even: 62.00%
Add to Inquiry Add to Inquiry Basket

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API).

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API). Opportunities for Entrepreneurs to Start Own Industry. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. Related Project: - Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac Sodium • Acecloflenac Active Pharmaceutical Ingredient (API) is the portion of drug that generates intentional effects. APIs are biologically and chemically active constituents of medicines with direct effect in mitigation, prevention, cure and treatment of diseases. Some of the medicines like combination therapies have many active ingredients to treat diverse symptoms or perform in numerous ways. Active Pharmaceutical Ingredient has active ingredient that is contained in medicine. For illustration, an active ingredient to reduce pain is incorporated in a painkiller. A slight amount of the active ingredient has result thus only small part of the active ingredient is confined in medicine. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Market Outlook Active Pharmaceutical Ingredients Market Dynamics The growing cases of chronic diseases are one of the leading causes of hospitalization, and a majority of the patients with these conditions may need re-admission in hospitals due to infection leading to other chronic diseases. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular disease in 2017. Besides, CDC has also stated that out of the total annual healthcare expenditure, i.e., USD 27 trillion, 86% is for the people with chronic health conditions in the US. Some of the prime factors spurring the growth of the market are increasing occurrences of cardiovascular, oncology, lifestyle and diabetes diseases, intensifying number of diagnostic centers and hospitals and escalating elderly population in emerging countries. Furthermore, cumulative healthcare spending, growing disease responsiveness and education are propelling the growth of the market. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing With advancements in healthcare infrastructure, healthcare spending has increased over time. This augmenting focus on healthcare spending positively influences the market for active pharmaceutical ingredients. The high adoption rate of generic drugs in developed and developing economies is fueling the growth of the market. Another positive impact comes from the high demand for specialty medicines which is anticipated to escalate the spending in the pharmaceutical sector. Developed nations are expected to exhibit faster growth in these spending as compared to the developing economies on the back of factors such as the presence of adequate manufacturing units, transparent pricing, and higher spending power. Specialty medicines a trend in the active pharmaceutical ingredients market A higher generic adoption rate in developed countries that ranges from 27% to 32% is driving global medicine spending and aiding greater access to improved, lifesaving healthcare services. The adoption of branded generic drugs is predicted to be higher in emerging economies such as China and India and generic drugs accounted for nearly 80% of the total drugs sold by value in these fast-growing nations in 2016. Rising use of specialty medicines is anticipated to grow the pharmaceutical spending worldwide with quicker growth in richer, developed nations as compared to their emerging counterparts. This is primarily because the former have adequate manufacturing units, a higher spending power, and greater emphasis on transparent pricing by assessing measuring effects on the population. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription. The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs. Key Players:- Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd. Sanofi India Ltd. Sri Krishna Pharmaceuticals Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd. Triton Laboratories Ltd. Tags: - #APIBusiness #apimanufacturing #Apiproduction #APImarket #APIProject #ApiStartup #APIindustry #Activepharmaingredients #pharmaingredients #IndianPharma, #medicineingredients #CoronavirusBusiness #COVID2019 #Activepharmaingredientbusinessplan #APIbusinessplan #APIbusinessidea #startupAPIbusiness #Activepharmaingredientmanufacturing #APIproduction #API #Azithromycin #Cefixime #Telmisartan #Diclofenacsodium #Acecloflenac #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #entrepreneurindia #startupbusiness #startupbusinessideas #howtostartbusiness #InvestInStartups #Plan4Business #StartupProject #ProjectReport #startupplan #BusinessKaiseshurukare #BusinessProjectReport
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Business Plans of Surgical Latex and Nitrile Gloves, Used and Waste Oil Recycling Plant, Chlorinated Polyvinyl Chloride, Gourmet Popcorns, Camphor Powder, Meat Analogue, HDPE and PP Bags, Disposable Plastic Syringes.

Business Plans of Surgical Latex and Nitrile Gloves, Used and Waste Oil Recycling Plant, Chlorinated Polyvinyl Chloride, Gourmet Popcorns, Camphor Powder, Meat Analogue, HDPE and PP Bags, Disposable Plastic Syringes. Coming up with a great business idea is just the beginning of your journey as an entrepreneur. Best startup business ideas means a lot to your startup business growth. People today follow their dreams and choose their passion over money. They are always in search of best startup business ideas which can feed their passion. Today, millions of people desire to start their own business, leaving the traditional 9 to 5 job. Most of the people in this world have to chase two or three carriers during their work life. One of the most gratifying things in the world is to work for yourself. Owning your own business, while it can be stressful, is meaningful because the effort you put in helps you personally, rather than building something for someone else. Projects: - Project Reports & Profiles Used and Waste Oil Recycling Plant Re-refining of used lube oil is an economically attractive recycling method in terms of resources conservation and environment protection. It allows processing of hazardous material during a secure and effective thanks to recover a high quality base oil product. Waste oil is generated from industrial and non-industrial sources and primarily contains hydrocarbons. It’s getting to also contain additives and impurities due to physical contamination and chemical reactions occurring during its use. Used oil has been used previously, and as a results of that, is now contaminated by impurities, either chemical or physical. Samples of used oil are old transmission oil, motor oil, brake fluid, hydraulic oil and gearbox oil. Used oil could also be a recyclable commodity, and intrinsically, are often stored for recycling, reuse or disposal. Used oil isn't considered to be a waste product. The global lubricants market size was valued at USD 126.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 3.6% from 2020 to 2027. The global manufacturing sector has a direct impact on the lubricants demand as they are used in numerous industries including paper and mill, metal forming, foundry, mining, quarrying, energy, plastics, food and beverages, and machining. The enhanced properties of drugs oils are required to enhance the efficiency of the wind turbine; hence there is an increasing demand for synthetic gear oils in wind turbines. Power generation from wind energy is rising at a swift speed that's also demanding for installation of wind turbines. Wind turbines are fueling the demand for gear oils that are driving the Indian industrial lubricants market. Manufacturing of CPVC (Chlorinated Polyvinyl Chloride) Chlorinated polyvinyl chloride (CPVC) may be a thermoplastic produced by chlorination of polyvinyl chloride (PVC) resin, which is significantly more flexible and may withstand higher temperatures than standard PVC. Uses include hot and cold water delivery pipes and industrial liquid handling. CPVC, as PVC, is deemed safe for the transport and use of potable water, potable meaning water used for drinking, cooking, and bathing. The demand for PVC in India witnessed a strong CAGR within the historic years and is projected to realize a healthy CAGR of over 6.81% during 2015-2030. The whole capacity of PVC in India is around 1640 KTA with Reliance Industries holding maximum share in its production as compared to the other four leading players. The domestic production of PVC is unable to consolidate the large demand for the merchandise hence; around 50 per cent of the demand in India is being met through imports. CPVC Applications ? Hot- and cold-water plumbing distribution, residential and commercial ? Fire protection: One- and Two-Family Dwellings and Manufactured Homes (NFPA 13D), Low-Rise Residential Occupancies (NFPA 13R) and Light Hazard Occupancies (NFPA 13) ? Reclaimed water piping (purple pipe) ? Chilled water piping ? Hydronic piping and distribution (radiators, fan coils, etc.) ? Suitable for many industrial and process piping applications However, chlorinated polyvinyl chloride products turns brittle after a short time due to continuous exposure to hydrocarbon chemicals or losing the molecular bond in CPVC materials. It’s getting to create hassles for the merchandise manufacturer. Additionally, there's problem of high maintenance of fabric in leak damage situations, which tends to affect product demand. This might play a setback for product demand over the forecast timeframe. Production of Gourmet Popcorns (Popped Corn, Popcorns or Pop-Corn) Gourmet Popcorn is extremely popular this days. Number of people’s don’t conscious of what gourmet popcorn is. Will discuss below how gourmet popcorn is different from other platform. Popcorn is formed up special sort of corn i.e. corn Evert from which tasty popcorn is produced which everyone like to have. It’s very healthy food to eat all the age people love to eat popcorn. It’s extremely solid sustenance to eat all the age individuals like to eat popcorn. The rationale popcorn 'pops' may be a results of a better than ordinary dampness content inside the portion, and a harder than typical bit, or shell, encompassing that dampness. Popcorn could also be a variety of corn kernel which expands and puffs up when heated the same names are also wont to discuss with the foodstuff produced by the expansion. A popcorn kernels strong hull contains the seed's hard, starchy shell endosperm with 14–20% moisture, which turns to steam because the kernel is heated. Pressure from the steam continues to form until the hull ruptures, allowing the kernel to forcefully expand, from 20 to 50 times its original size, then cool. Popcorn is one in every of the six major kinds of corn, which incorporates dent corn, flint corn, pod corn, soft corn , and sweet corn. Each kernel of popcorn contains a specific amount of moisture and oil. Unlike most other grains, the outer hull of the popcorn kernel is both strong and impervious to moisture and thus the starch inside consists almost entirely of a tough type. The global popcorn market is projected to reach $15billion by 2023, registering a CAGR of 7.6 percent from 2017 to 2023, with ready-to-eat leading the segment. While established FMCG businesses have either launched a popcorn product or are looking to launch one, startups too have built ready-to-eat or ready-to-cook popcorn brands within the domain. It might be futile to undermine the potential this industry has. The future of India Snacks Market are often judged from the very fact that this industry is expected to grow with integer CAGR for the time-frame of 2018 to 2024. India snacks market is dived between organized players and unorganized market. At the present Unorganized market is dominating the India snacks market. But this scenario is predicted to vary during the forecast period of 2018-2024. India Snacks Market is growing because of following factors Lifestyle Changes, Rising Urbanization, Growing middle class Population, Local Availability and Availability of Snacks in Small Package Size, Low Price and Company’s Strategies to specialize in regional taste. Camphor Powder (Kapoor/ Kapur) Making Business Plan Camphor (Cinnamomum camphor) may be a white, crystalline substance with a strong odor and pungent taste, derived from the wood of camphor laurel (Cinnamomum camphor) and other related trees of family Lauraceous. Camphor tree is native to China, India, Mongolia, Japan and Taiwan and a selection of this fragrant evergreen tree is grown in Southern United States; Especially in Florida. Camphor is obtained through steam distillation, purification and sublimation of wood, twigs and bark of the tree. There are many pharmaceutical applications for camphor like topical analgesic, antiseptic, antispasmodic, antipruritic, anti-inflammatory, anti-infective, rubefacient, contraceptive, mild expectorant, decongestant , cough suppressant, etc. Camphor is certainly absorbed through the skin and should even be administrated by injection, inhalation and ingestion. Global camphor market is anticipated to grow at a CAGR of 7.9% over the forecast period. Factor such as the growing demand of the camphor in making medicine for various sort of diseases is predicted to drive the growth of the camphor market in upcoming years. Because of good chemical properties it's wide selection of application in various user industries such as pharmaceuticals, food, agriculture and chemical among several others. It’s also used for creating ointments with vapor for treating cough and chest congestion. Rising demand of camphor for the ointments is anticipated to drive the expansion for the market. Camphor are witnessed to experience high demand from various end-users within the global market. Due to the advantages provided by camphor for various applications has led to high demand for camphor within the market. Camphor provides high medicinal benefits such as pain and swelling reduction, relief from congestion and cough, relieves wiped out muscles, sprains, etc. Camphor is additionally utilized in manufacturing wide selection of Ayurvedic medicines. Growing demand from the pharmaceutical industry has therefore led to high demand for camphor within the market. Plant?Based Meat Alternatives -Meat Analogue, Vegan Meat & Mock Meat Manufacturing from Soyabean and Wheat Gluten A meat analogue may be a meat-like substance made up of plants. More common terms are plant-based meat, vegan meat, meat substitute, mock meat, meat alternative, imitation meat, or vegetarian meat, or, sometimes more pejoratively, fake meat or faux meat. Meat analogues typically approximate certain aesthetic qualities (such as texture, flavor, and appearance) or chemical characteristics of specific varieties of meat. Generally, meat analogue means a food made up of vegetarian ingredients, and sometimes without animal products such as dairy. Many analogues are soy-based (e.g. tofu, tempeh) or gluten-based, but now can also be made up of pea protein. Other less common analogues include ingredients like mycoprotein. A meat analogue, also mentioned as a meat alternative or substitute, or as mock, imitation, vegetarian, or vegan meat, approximates certain aesthetic qualities (such as texture, flavor, and appearance) or chemical characteristics of specific varieties of meat. Generally, meat analogue means a food made from vegetarian ingredients, and sometimes without animal products such as dairy. Many analogues are soy-based (e.g. tofu, tempeh) or gluten-based, but now also can be made from pea protein. The target market for meat analogues includes vegetarians, vegans, non-vegetarians seeking to reduce their meat consumption, and people following religious dietary laws in Hinduism, Judaism, Islam, and Buddhism. Increasingly the global demand for sustainable diets in response to the outsized role animal products play in global warming and other environmental impacts has seen an increase in industries focused on finding substitutes similar to meat. There has been an increased leaning towards non-meat based protein alternatives. International players such as Impossible Foods and Beyond Meat which offer substitute products for meat have been doing brisk business. In fact, reports predict that the global meat substitute market size which was valued at $4.1 billion in 2017 is expected to scale up to $8.1 billion by 2026. India meat substitutes market is predicted to grow at a CAGR of on the brink of 10% during the forecast period. The India meat substitutes market is driven by rising health concerns including growing awareness about various diseases caused because of lack of proteins among consumers. Also, increasing vegan population in India is predicted to bolster the expansion of market over following few years. Growing demand for plant-based meat products among the population is further aiding the expansion of India meat substitutes market over the approaching years. Manufacturing of High Density Poly Ethylene (HDPE) and Polypropylene (PP) Bags High-density polyethylene (HDPE) or polyethylene high-density (PEHD) is a thermoplastic polymer produced from the monomer ethylene. It is sometimes called "alkathene" or "polythene" when used for HDPE pipes. With a high strength-to-density ratio, HDPE is used in the production of plastic bottles, corrosion-resistant piping, geomembranes and plastic lumber. HDPE is commonly recycled, and has the number "2" as its resin identification code. The global HDPE market reached a volume of more than 30 million tons. At the present there's underutilization of existing capacity due to marketing problems after introducing of Jute packaging Mandatory Order 1986. The demand for woven sacks was sluggish for a variety of reasons. A few of year’s back Flat looms were used for the manufacture of woven sacks. Now it has been manufactured on circular looms, which have high productivity. This helped in minimizing the worth of production; however due to high cost of jute bags & also due to resistance to chemicals, moisture etc. most of industry prefer HDPE/PP woven sacks for packaging. Lighter in weight & have more advantages than conventional bags. PP/HDPE woven sacks laminated with LDPE/PP liner have wider applications. HDPE woven sacks are much stronger & can withstand much higher impact loads because of HDPE strips elongation at break is about 15-25% as compared to 30% of Jute. These sacks are much cleaner & resist fungal attack. Jute prices are very unstable within the market since Jute is an agriculture product. These sacks have many advantages over other conventional sacks materials & are quite competitive in price. Woven Packaging Fabrics, Woven bags and fabrics are often used as an industrial packaging material. The packaging bags and fabrics are available mostly in HDPE (High Density Polythene) and PP (Polypropylene). Counting on end use these are either laminated, or supplied without lamination. Based on material type, the worldwide plastic bags and sacks market is segmented into biodegradable and non-biodegradable. The biodegradable segment is further segmented into polyl actic acid (PLA), poly-hydroxyl-alkanets (PHA), and starch blend resins, while the non-biodegradable segment is further segmented into density polyethylene (LDPE), high density polyethylene (HDPE), polypropylene (PP), linear rarity polyethylene (LLDPE), and polystyrene (PS). Changes in consumer lifestyle, rapid pace of industrialization, rising commodity and retail sector, and declining prices of oil and gas in emerging markets are the factors accentuating market growth. The worldwide marketplace for plastic bags and sacks is forecast to expand at a CAGR of over 3.4% from 2016 to 2024. Start a Disposable Plastic Syringes Manufacturing Business Plastics are finding greater use in medical disposables and replacing conventional materials like metals and glass. One such application which has been established within the country is that the use of disposable syringes produced from polypropylene resin by the process of injection molding. The components include the plunger, main body which is graduated to point capacity, gasket, needle holder and therefore the sheath protect the needle. The individual syringes are over wrapped during a polyethylene film pouch for subsequent sterilization by ethylene oxide/gamma radiation. Disposable Syringes are made up of plastic material and are utilized within the sector of medical and veterinary science. Due to their availability in sterilized condition, ready to use, and price effectiveness, disposable syringes are fast replacing the age-old glass syringes. The constantly increasing use of this type Syringe indicates its importance which is predicated mainly on the advantages it offers regarding cost and hygienic applications. The manufacture of plastic syringes has been developed to such a degree that the products now satisfy the wants and standards set by Hospital and physicians. At the same time they provide the foremost effective possible technique of application to the physician and thus the very best possible degree of safety to the patient. Disposable syringes commonly are utilized in modern medicine for the injection of medication and vaccines or for the extraction of blood. The usually are used rather than reusable syringes in an attempt to avoid spreading a disease. Among the common uses of disposable syringes are the injecting of insulin by a diabetic person and therefore the administering of an area anesthesia by a dentist. In medical industries syringes are very important and play a significant role. It’s a medical device which is used to inject or withdraw fluids from the body. Numerous categories of syringes are employed by medical examiners counting on the situations. The aim behind using syringes is to wash wounds by infusing fluids into body. Syringes are used for distillation of blood, for vaccination, for infusing of insulin, for governing anesthesia etc. The market of medical disposables holds the revenue of roughly USD 225 billion in 2016 at a CAGR of around 7% over the forecast period i.e. 2016-2024 during which global syringes market accounted for USD 5 billion in 2016 because of increasing number of chronic diseases so on. On the basis of products disposable syringes are the dominating market with a CAGR of around 6% over the forecast period i.e. 2016-2024 because disposable syringes are used only once ensuring the safety of patients. On the basis of material, glass syringe is dominating the segment and is expected to reach a value of USD 15 million by 2024 because they can be sterilized and reused. The syringes market is expected to reach USD 15.99 Billion by 2021 from USD 10.56 Billion in 2016, at a CAGR of 8.7% during the forecast period. Manufacturing of Surgical (Surgeons) Latex and Nitrile (NBR-Nitrile Butadiene Rubber) Gloves. NBR latex may be a synthetic milky colored latex that's widely utilized in dripping rubber for laboratory and medical gloves. These latexes possess excellent properties such as lastingness and oil resistance among others which makes them highly desirable within the healthcare industry. These excellent properties also will help to drive the demand for NBR latex gloves within the food and industrial applications. A surgical (surgeon’s) glove is made of natural or synthetic rubber intended to be worn by operating theatre personnel to safeguard a surgical wound from contamination. Surgical gloves have more precise sizing (numbered sizing, generally from size 5.5 to size 9), and are made to higher specifications. They’re hand specific. Due to the increasing rate of latex allergy among health professionals also as within the general population, there has been an increasing move to gloves made up of non-latex materials such as vinyl or nitrile rubber. However, these gloves haven't yet replaced latex gloves in surgical procedures, as gloves manufactured from alternate materials generally don't fully match the fine control or greater sensitivity to the touch available with latex surgical gloves. Nitrile gloves are a type of disposable gloves made from synthetic rubber this means there is no risk of latex allergies. They are the most popular gloves type in our range and offer superior strength, dexterity and resistance to oils and aqueous chemicals in comparison to vinyl or latex. For these reasons, they are often used in the medical, laboratory and manufacturing industries. India disposable gloves market generated $303 million in 2017, and is projected to reach $760 million by 2025, growing at a CAGR of 12.4% from 2018 to 2025. In terms of volume, the market is growing at a CAGR of 8.3% from 2018 to 2025. Market Research: - Market Research Report The Indian marketplace for medical gloves remains evolving. While the worldwide market is growing at a compound annual rate of growth (CAGR) of two per cent, the Indian market is at seven per cent growth. Each day there is a replacement hospital or home doping up in India, therefore the demand for medical gloves is predicted to increase. Medical tourism is additionally driving the expansion of this product category in our country. The market size therefore only for surgical gloves in India is Rs 300 crore. In sight of all this, there's an honest scope to initiate small-scale rubber gloves manufacturing unit. The demand for rubber gloves is rapidly increasing on account of rapid industrialization and urbanization of our country currently happening. Several workers within the chemical, electrical and food processing industries use rubber gloves. Similarly, the amount of individuals using gloves for household purposes during handling of detergents, floor polishes, and pesticides and therefore the like is additionally increasing especially within the urban areas. Related Books: - BOOKS & DATABASES Tags:- #latexgloves #LatexGlovesproduction #LatexGlovesbusinessplan #OilRecycling #OilRecyclingBusinessplan #chlorinatedpolyvinylchloride #cpvcandpvc #ChlorinatedPolyvinylChloridebusinessplan #CPVCmanufacturing #GourmetPopcorns #GourmetPopcornsBusinessplan #CamphorPowdermanufacturing #CamphorPowder #CamphorPowderbusinessplan #MeatAnalogue #MeatAnaloguebusinessplan #HighDensityPolyEthylene #HighDensityPolyEthylenestartup #HighDensityPolyEthyleneproduction #HighDensityPolyEthylenebusinessplan #HDPEbag #Polypropylenemarket #Polypropylenemanufacturing #polypropylenebags #MedicalDevicesIndustry #disposablePlasticSyringes #MedicalDevicesIndustry #disposablePlasticSyringesbusinessplan #DisposableProduct #Latexgloves #Latexglovesbusinessplan #howtostartbusiness #businessgrowth #businesstoday #startupbusiness #BusinessPlan #business4you #ProjectReprot #businessplanning #potentialbusinessidea #Startupbusiness4you #StartupBusinessPlan #StartupIndiaConsultants #startupinvestment #startupbusinessidea #startup2020 #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient. Investment Opportunity for Startups and Entrepreneurs. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. Ciprofloxacin is FDA approved for the treatment of urinary tract infections, sexually transmitted infections (gonorrhea and cancroid), skin, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Uses and Applications Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Mycoplasma contamination is a major problem in cell culture in biomedical and biopharmaceutical research, with rates near 15-30%. While there is no method for visual confirmation of mycoplasma, contamination has serious effects on key characteristics and functions of cells, thus compromising any research done. Cipro (ciprofloxacin hydrochloride) is the standard antibiotic for rapid and efficient decontamination. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks CIPRO is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis. Ciprofloxacin (Cetraxal, Ciloxan, and Cipro) is an inexpensive drug used to treat certain bacterial infections. It is more popular than comparable drugs. Application Urogenital Infections Respiratory Tract Infections Gastrointestinal Infections Typhoid Bone and Joint Infections Skin and Soft Tissue Infections Sepsis and Other Systemic Infections Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Government Initiatives • Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: • India plans to set up a nearly Rs 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023. • In November 2019, the Cabinet approved extension/renewal of extant Pharmaceuticals Purchase Policy (PPP) with the same terms and conditions while adding one additional product namely, Alcoholic Hand Disinfectant (AHD) to the existing list of 103 medicines till the final closure/strategic disinvestment of Pharma CPSUs. • Under Budget 2020-21, Rs 65,012 crore (US$ 9.30 billion) has been allocated to the Ministry of Health and Family Welfare is. The Government has allocated Rs 34,115 crore (US$ 4.88 billion) towards the National Health Mission under which rural and urban people will get benefited. • Rs 6,400 crore (US$ 915.72 million) has been allocated to health insurance scheme Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). • As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 per cent in FY20 from 1.2 per cent in FY15 on health. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates • The National Health Protection Scheme is the largest Government funded healthcare programme in the world, which is expected to benefit 100 million poor families in the country by providing a cover of up to Rs 5 lakh (US$ 7,723.2) per family per year for secondary and tertiary care hospitalisation. The programme was announced in Union Budget 2018-19. • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy to stop any misuse due to easy availability. • Government of India unveiled 'Pharma Vision 2020' to make India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investment. • India has imposed a provisional anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China on the grounds that it was hurting domestic industry, following an investigation of the Directorate General of Trade Remedies (DGTR). • The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. • Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections and certain types of diarrhea. The DGTR had initiated the investigation in January this year. Related Videos: - Industrial, Medical and Specialty Gases Manufacturing Project Ideas Market Outlook The India ciprofloxacin market is segmented based on composition, source, and form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, optic, and intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability. The Global Ciprofloxacin Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027. Related Project:- Ciprofloxacin Hydrochloride Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. The remaining of the active pharmaceutical ingredient of ciprofloxacin is being dispersed in another combination product and specifically utilize in the urinary tract antibiotic only. Thereby anticipated to lure the new market players in the ciprofloxacin market. The higher incidence of skin and immunological disorder is anticipated to offer a steady revenue generation opportunity in the ciprofloxacin market. Increase awareness about safe drug utilization, however increase in adverse drug reaction awareness and stringent government impositions have narrowed the growth path for global Ciprofloxacin market in North America. Furthermore in East Asia region considerably higher market growth rate is expected due to higher utilization of ciprofloxacin in renal infection in the region. Thereby anticipated to increase the revenue generation in the Ciprofloxacin market. Related Projects: - Chemicals (Organic, Inorganic, Industrial) Projects The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. Related Projects: - Active Pharma Ingredients(API) Key Players:- ? Aarti Drugs Ltd. ? Aurobindo Pharma Ltd. ? Cipla Ltd. ? Indoco Remedies Ltd. ? Kores (India) Ltd. ? Mylan Pharmaceuticals Pvt. Ltd. ? Neuland Laboratories Ltd. ? S S Organics Ltd ? Smruthi Organics Ltd. ? Sreepathi Pharmaceuticals Ltd. ? Sterling Basic Organics Ltd. ? Sun Pharma Laboratories Ltd. ? Sun Pharma Medisales Pvt. Ltd. ? Wockhardt Ltd. Tags:- #CiprofloxacinHydrochloride #Ciprofloxacin #CiprofloxacinBusinessPlan #activepharmaceuticalingrediants #activepharmaingredient #Pharmaceutical #pharmaindustry #APIManufacturing #APIProduction #APImarket #APIBusiness #APIbusinessplan #startupAPIbusiness #CIPRO #startyourbusiness #investmentopportunity #covidbusiness #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #ChemicalIndustry
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes

Disposable Syringes are made of plastic material and are used in the field of medical and veterinary science. Due to their availability in sterilized condition, ready to use, and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. The constantly increasing use of this type Syringe indicates its importance which is based mainly on the advantages it offers regarding cost and hygienic applications. The manufacture of plastic syringes has been developed to such a degree that the products now satisfy the requirements and standards set by Hospital and physicians. At the same time they offer the best possible technique of application to the physician and the highest possible degree of safety to the patient. Disposable Syringes are being used by doctors to inject medicines through intravenous or intramuscular ways for the treatment of diseases & also by research & development personnel. Disposable syringes are made of plastic material and are used in the field of medical and veterinary science. Due to their availability in sterilized condition, ready to use, and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. Disposable needles are becoming more popular in the medical world due to its lower cost and higher accuracy. The procedure is also relatively easy and cheaper. The disposable needle has widely replaced hypodermic needle because of lower cost, easy compatibility and higher sterilization. Disposable needle is widely used by doctors for injection purpose with the help of syringes. With the increase in population in our country, requirement of medicine and injections has increased. The Disposable Syringes market was valued at USD 7.10 billion in 2019 and is predicted to grow at a CAGR of 6.1% during the forecast period and is anticipated to reach USD 12.91 Billion by 2027. The growth of the market is attributed to growing prevalence of chronic diseases, especially diabetes, an increase in the usage of Botox, increased adoption of inject able drugs, technological advancements in syringes, an increase in the geriatric population, a growing number of vaccination and immunization programs. Based on the WHO estimates, 16 billion injections are administered each year globally. A Disposable Syringes is a medical tool used to administer injections of intravenous drugs into the patient’s blood stream or to draw blood sample. The syringe market is expected to witness a robust growth owing to several factors, such as the rise in the demand for pre-filled syringes, growing prevalence of chronic diseases, such as diabetes, infectious diseases and cardiovascular diseases and the increase in the usage of Botox for therapeutic applications. Moreover, the increased adoption of inject able drugs, technological advancements in syringes, the increase in the geriatric population, growing number of vaccination and immunization programs are expected to drive the volume growth over the next few years. According to WHO estimates, around 16 billion injections are administered globally on an annual basis. On the other hand, the rise in the incidence of needle-stick injuries, a high cost associated with safety syringes, and disposable syringes are likely to hinder the growth of the syringe market globally. This facilitates the development of new technologies and ensures a high quality product. Few Indian major players are as under Baxter Pharmaceuticals India Pvt. Ltd. Becton Dickinson India Pvt. Ltd. Hindustan Syringes & Medical Devices Ltd. Novo Nordisk India Ltd. Lifelong Meditech Ltd. Oyster Medisafe Pvt. Ltd. Peekay Mediequip Ltd
Plant capacity: Disposable Plastic Syringes 2 ml Size: 2,000 Boxes/ Day (Each Box = 100 Pcs.) Disposable Plastic Syringes 3 ml Size: 2,000 Boxes/ Day (Each Box = 100 Pcs.) Disposable Plastic Syringes 5 ml Size: 2,000 Boxes/ Day (Each Box = 100 Pcs.)Plant & machinery: Rs 1100 lakhs
Working capital: -T.C.I: Cost of Project : Rs 2006 lakhs
Return: 15.00%Break even: 47.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes with Needles Manufacturing

Disposable Syringes are made of plastic material and are used in the field of medical and veterinary science. Due to their availability in sterilized condition, ready to use, and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. The constantly increasing use of this type Syringe indicates its importance which is based mainly on the advantages it offers regarding cost and hygienic applications. The manufacture of plastic syringes has been developed to such a degree that the products now satisfy the requirements and standards set by Hospital and physicians. At the same time they offer the best possible technique of application to the physician and the highest possible degree of safety to the patient. Disposable needles are becoming more popular in the medical world due to its lower cost and higher accuracy. The procedure is also relatively easy and cheaper. The disposable needle has widely replaced hypodermic needle because of lower cost, easy compatibility and higher sterilization. Disposable needle is widely used by doctors for injection purpose with the help of syringes. With the increase in population in our country, requirement of medicine and injections has increased. A syringe is a medical device used for injecting fluids into the body, or to withdraw fluid from the body. A typical medical syringe has a needle attached to a hollow cylinder, which is fitted with a sliding plunger. By pushing the plunger in downward movement, the fluids are injected in a body, and retracting the plunger in upward direction extracts fluids from the body. The global prefilled syringes market size is expected to reach a value of USD 22.5 billion by 2025, according to a by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.2% during the forecast years. Growing usage of prefilled syringes and technological advancements in auto-injectors are the key factors driving the market. These syringes enable easy management of chronic diseases, such as diabetes and rheumatoid arthritis, which is expected to boost the usage of auto injectors and pen injectors during the forecast period. Thus, growing prevalence of diabetes and other chronic diseases would fuel the market demand over the next few years. The introduction of advanced devices with Wi-Fi and Bluetooth connectivity facilitating effective management of patient health records is also expected to boost the product demand. The global syringe market is expected to witness robust growth owing to several factors such as rise in demand for pre-filled syringes, growing prevalence of chronic diseases such as diabetes, increase in usage of Botox for therapeutic applications. Moreover, the growing number of vaccination and immunization programs are expected to drive strong volume growth over the next few years. Increased adoption of inject able drugs, technological advancements in syringes, increase in geriatric population and increase in demand for vaccination are some of the other factors contributing to the growth of the market. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players are as under Hindustan Syringes & Medical Devices Ltd. Lifelong Meditech Ltd. Schott Kaisha Pvt. Ltd. Disposable Medi-Aids Ltd. Peekay Mediequip Ltd.
Plant capacity: Disposable Plastic Syringes with Needle 1 ml Size) : 18,000 Nos / Day Disposable Plastic Syringes with Needle 3 ml Size) : 18,000 Nos / Day Disposable Plastic Syringes with Needle 5 ml Size) : 18,000 Nos / Day Disposable Plastic Syringes with Needle 10 Plant & machinery: Rs 108 lakhs
Working capital: -T.C.I: Cost of Project : Rs 498 lakhs
Return: 31.00%Break even: 44.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 14 of 27 | Total 263 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 26 27   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top